Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice

about

A retrospective analysis of the Alzheimer's disease vaccine progress - The critical need for new development strategies.

P2860

Q34518856-70402EBC-2BD4-45A2-AA6F-380E034931C8

P2860

Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice

Item

http://www.wikidata.org/entity/Q35816969

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice

@ast

Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice

@en

type

Item

label

Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice

@ast

Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice

@en

prefLabel

Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice

@ast

Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice

@en

P1476

Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice

@en

P2093

Ajeet Rijal Upadhaya

http://www.w3.org/2001/XMLSchema#string

Dorothee Abramowski

http://www.w3.org/2001/XMLSchema#string

Haruyasu Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Julia Reichwald

http://www.w3.org/2001/XMLSchema#string

Julia Steinmetz

http://www.w3.org/2001/XMLSchema#string

Karthikeyan Balakrishnan

http://www.w3.org/2001/XMLSchema#string

Marcus Fändrich

http://www.w3.org/2001/XMLSchema#string

Matthias Staufenbiel

http://www.w3.org/2001/XMLSchema#string

P2860

Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease.

Amyloid plaque core protein in Alzheimer disease and Down syndrome

Transmission and spreading of tauopathy in transgenic mouse brain

Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease

Reversible memory loss in a mouse transgenic model of Alzheimer's disease

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis

Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides.

UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain.

P2888

s40478-015-0217-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40478-015-0217-Z

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dietmar R. Thal

Jochen Walter

Sathish Kumar

P577

2015-07-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280008042

http://www.w3.org/2001/XMLSchema#string

P6179

1006316631

http://www.w3.org/2001/XMLSchema#string

P698

26141728

http://www.w3.org/2001/XMLSchema#string

P932

4491274

http://www.w3.org/2001/XMLSchema#string

Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice

about

P2860

P2860

Impact of amyloid β aggregate maturation on antibody treatment in APP23 mice

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932